28 August 2017 1 Min Read
ROCHE NEGOTIATIONS
State in push for affordable cancer drug
Department of Health was hoping to finalise its negotiations with Swiss pharmaceutical firm Roche to cut the price of its breast-cancer drug Herceptin by November 2017
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In